OpenVSafe by OpenVAERS
Search V-safe

6A4-16830-38862

3 vaccinations 2 coded responses 17 check-ins 2 free-text entries 0 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
281 / NC
Registered
2021-01-12
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-11
    Dose 1 — Moderna
  2. 2021-01-12
    Registered in v-safe
  3. 2021-01-12
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2021-01-13
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache
    Adult check-in
  5. 2021-01-14
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-01-15
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-01-18
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-25
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  9. 2021-02-01
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  10. 2021-02-08
    Dose 2 — Moderna
  11. 2021-02-15
    Health check-in — day 7, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  12. 2021-02-22
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-03-01
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  14. 2021-03-08
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-05-10
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-08-09
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  17. 2022-02-10
    Survey response — 12 months, dose 2
    MedDRA: Bronchitis, Immune system disorder, Nasopharyngitis, Pre-existing disease — Feeling: Good · Be unable to do your normal daily activities
    Free text: Had Covid. Lost sense of taste and smell for several days. Had brain fog. Not hospitalized. Had weakened immune system for weeks after leading to bronchitis and cold symptoms for 6-8 weeks after Covid.
    MedDRA releases: 2024-11 · check-in free text available
  18. 2022-04-21
    Dose 3 — Moderna
  19. 2022-04-27
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymph node pain — Feeling: Good · Site: Pain, Redness, Swelling, Itching
    Free text: Pain in lymph nodes
    MedDRA releases: 2024-11 · check-in free text available
  20. 2022-04-30
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  21. 2022-05-28
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-01-11Moderna
22021-02-08Moderna
32022-04-21Moderna No

Free text

Release 11 — 12 months, dose 2

2022-02-10

Symptoms: Had Covid. Lost sense of taste and smell for several days. Had brain fog. Not hospitalized. Had weakened immune system for weeks after leading to bronchitis and cold symptoms for 6-8 weeks after Covid.

Release 11 — days 1–6 daily, dose 3

2022-04-27

Systemic reaction (other): Pain in lymph nodes

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDBronchitis · · ✓
SDImmune system disorder · · ✓
SDNasopharyngitis · · ✓
SDPre-existing disease · · ✓
SROLymph node pain · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release